Problems and Limitations of Meta-Analyses within the Framework of Evidence-Based Medicine

Publisher： Karger

E-ISSN： 1424-0556|1|5|260-267

ISSN： 1422-9528

Source： Heart Drug, Vol.1, Iss.5, 2002-01, pp. : 260-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials and Evidence-Based Medicine

By  

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Meta-Analyses and Conflict of Interest

By Fava Giovanni A.  

CNS Drugs, Vol. 26, Iss. 2, 2012-02 ,pp. : 93-96

Adis International

Access to resources Recommend Favorite

Evidence-based medicine's role in clinical practice

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 347, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Insulin Aspart: An Evidence-Based Medicine Review

By Alan Haycox  

Clinical Drug Investigation, Vol. 24, Iss. 12, 2004-01 ,pp. : 695-717

Adis International

Access to resources Recommend Favorite

A General Approach for Combining Voxel-Based Meta-Analyses Conducted in Different Neuroimaging Modalities

By  

Current Medicinal Chemistry, Vol. 20, Iss. 3, 2013-01 ,pp. : 462-466

Bentham Science Publishers

Access to resources Recommend Favorite